HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.

AbstractBACKGROUND:
Breast cancer is the common cancer in China. In previous study, we determined that 3,6-dihydroxyflavone (3,6-DHF) increases miR-34a significantly in breast carcinogenesis, but the mechanism remains unclear.
METHODS:
We used qRT-PCR to analyze miR-34a and ten-eleven translocation (TET)1, TET2, TET3 levels in breast cancer cells. With a cellular breast carcinogenesis model and an experimental model of carcinogenesis in rats, TET1 levels were evaluated by western blot analysis and immunofluorescence. TET1 and 5hmC (5-hydroxymethylcytosine) levels were evaluated by immunofluorescence in nude mouse xenografts of MDA-MB-231 cells. Chromatin immunoprecipitation(ChIP) assayed for TET1 on the TET1 promoter, and dot blot analysis of DNA 5hmC was performed in MDA-MB-231 cells. We evaluated the mechanism of 3,6-DHF on the expression of tumor suppressor miR-34a by transfecting them with DNA methyltransferase (DNMT)1 plasmid and TET1 siRNA in breast cancer cells. Methylation-specific PCR detected methylation of the miR-34a promoter.
RESULTS:
First, we found that 3,6-DHF promotes the expression of TET1 during carcinogen-induced breast carcinogenesis in MCF10A cells and in rats. 3,6-DHF also increased TET1 and 5hmC levels in MDA-MB-231 cells. Further study indicated that TET1 siRNA and pcDNA3/Myc-DNMT1 inhibited the 3,6-DHF reactivation effect on expression of miR-34a in breast cancer cells. Methylation-specific PCR assays indicated that TET1 siRNA and pcDNA3/Myc-DNMT1 inhibit the effect of 3,6-DHF on the demethylation of the miR-34a promoter.
CONCLUSIONS:
Our study showed that 3,6-DHF effectively increases TET1 expression by inhibiting DNMT1 and DNA hypermethylation, and consequently up-regulates miR-34a in breast carcinogenesis.
AuthorsXiaoli Peng, Hui Chang, Junli Chen, Qianyong Zhang, Xiaoping Yu, Mantian Mi
JournalBMC cancer (BMC Cancer) Vol. 17 Issue 1 Pg. 619 (Sep 05 2017) ISSN: 1471-2407 [Electronic] England
PMID28870206 (Publication Type: Journal Article)
Chemical References
  • 3,6-dihydroxyflavone
  • Flavonoids
  • MIRN34 microRNA, human
  • MicroRNAs
  • Proto-Oncogene Proteins
  • RNA, Small Interfering
  • Mixed Function Oxygenases
  • TET1 protein, human
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNMT1 protein, human
Topics
  • Animals
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic (genetics, metabolism)
  • DNA (Cytosine-5-)-Methyltransferase 1 (genetics)
  • DNA Methylation
  • Female
  • Flavonoids (pharmacology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Mice
  • MicroRNAs (genetics)
  • Mixed Function Oxygenases (genetics)
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins (genetics)
  • RNA Interference
  • RNA, Small Interfering (genetics)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: